These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9054316)

  • 1. [Third generation cephalosporins (cefoperazone, cefotaxime, ceftazidime and ceftriaxone) in the prevention and treatment of experimental plague in albino mice].
    Ryzhko IV; Tsuraeva RI; Pasiukov VV; Samokhodkina ED; Shcherbaniuk AI
    Antibiot Khimioter; 1996 May; 41(5):35-8. PubMed ID: 9054316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparative study of fluoroquinolones and 3rd-generation cephalosporins in the prevention and treatment of experimental plague caused by Yersinia pestis strains typical and serologically atypical with respect to F1].
    Ryzhko IV; Shcherbaniuk AI; Tsuraeva RI; Samokhodkina ED; Kasatkina IV; Tsetskhladze NS; Pasiukov VV; Roshchina NV
    Antibiot Khimioter; 1997; 42(1):12-6. PubMed ID: 9221699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cefoperazone in the prevention and treatment of experimental plague caused by typical and fraction-free pathogen strains in white mice].
    Pasiukov VV; Ryzhko IV; Tsuraeva RI; Samokhodkina ED; Roshchina NV
    Antibiot Khimioter; 1994 Aug; 39(8):37-40. PubMed ID: 7695439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of cefixime and cefepime vs. other cephalosporins in experimental plague of albino mice due to variants FI+ and FI- of the plague microbe].
    Ryzhko IV; Shcherbaniuk AI; Moldavan IA; Tsuraeva RI; Anisimov BI; Trishina AV
    Antibiot Khimioter; 2007; 52(9-10):24-7. PubMed ID: 20583467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ceftriaxone in prevention and treatment of experimental plague infection].
    Ryzhko IV; Samokhodkina ED; Zhigalova TA
    Antibiot Khimioter; 1993 Jan; 38(1):39-42. PubMed ID: 8060183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapeutic properties of the new cephalosporin antibiotic HR810 in laboratory animals.
    Klesel N; Limbert M; Schrinner E; Seeger K; Seibert G; Winkler I
    Infection; 1984; 12(4):286-92. PubMed ID: 6092278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prophylactic and therapeutic action of ceftazidime in comparison to that of cefotaxime and combined use of cefotaxime with other antibiotics in experimental plague of albino mice].
    Zurabian VA; Markovskaia EI; Ryzhkova VV; Makarovskaia LN
    Antibiot Khimioter; 1994; 39(9-10):40-4. PubMed ID: 7695449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cephalosporins of the third generation in therapy of children with severe infections].
    Samsygina GA
    Antibiot Khimioter; 2000; 45(12):32-3. PubMed ID: 11212493
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug utilisation review (DUR) of the third generation cephalosporins. Focus on ceftriaxone, ceftazidime and cefotaxime.
    Adu A; Armour CL
    Drugs; 1995 Sep; 50(3):423-39. PubMed ID: 8521766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Beta-lactam antibiotics (ampicillin, cefotaxime) in prevention of experimental plague in albino mice, caused by non-fractioned strains of the pathogen].
    Samokhodkina ED; Ryzhko IV; Tsuraeva RI; Pasiukov VV
    Antibiot Khimioter; 1994 Jul; 39(7):20-3. PubMed ID: 7840704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of etiotropic therapy of plaque infection induced by atypical strains of F1- phenotype plaque microbe].
    Ryzhko IV; Samokhodkina ED; Tsuraeva RI; Shcherbaniuk AI; Tsetskhladze NS
    Antibiot Khimioter; 1998; 43(9):24-8. PubMed ID: 9791683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental evaluation of prospects for the use of beta-lactams in plague infection caused by pathogens with plasmid resistance to penicillins].
    Ryzhko IV; Samokhodkina ED; Tsuraeva RI; Shcherbaniuk AI; Pasiukov VV
    Antibiot Khimioter; 1998; 43(11):11-5. PubMed ID: 10079860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of typhoid fever and other systemic salmonelloses with cefotaxime, ceftriaxone, cefoperazone, and other newer cephalosporins.
    Soe GB; Overturf GD
    Rev Infect Dis; 1987; 9(4):719-36. PubMed ID: 3125577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ultrastructural changes in liver of white mice, caused by isogenic F1+ and F1- strains of the plague pathogen, and correction of them with ceftriaxone].
    Bardakhch'ian EA; Ryzhko IV; Pasiukov VV; Samokhodkina ED
    Biull Eksp Biol Med; 1996 May; 121(5):589-93. PubMed ID: 8744147
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of cephalosporins in the treatment of bacterial meningitis in adults. Overview with special emphasis on ceftazidime.
    Norrby SR
    Am J Med; 1985 Aug; 79(2A):56-61. PubMed ID: 3895919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of the effects of four cephalosporins against Escherichia coli in vitro and in vivo.
    van Ogtrop ML; Mattie H; Guiot HF; van Strijen E; Hazekamp-van Dokkum AM; van Furth R
    Antimicrob Agents Chemother; 1990 Oct; 34(10):1932-7. PubMed ID: 2291658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of rifampicin in experimental plague infection].
    Makarovskaia LN; Shcherbaniuk AI; Bugaeva OK
    Antibiot Khimioter; 1993 Jul; 38(7):34-6. PubMed ID: 8161275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of bacterial resistance to the third generation cephalosporins and their clinical use.
    Kolár M; Látal T; Hájek V
    J Chemother; 1999 Aug; 11(4):260-5. PubMed ID: 10465127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
    Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibiotics of the aminoglycoside group (gentamicin, sisomicin and amikacin) in the prevention and treatment of experimental plague].
    Shcherbaniuk AI; Makarovskaia LN; Bugaeva OK; Kasatkina IV
    Antibiot Khimioter; 1992 May; 37(5):30-1. PubMed ID: 1417325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.